IgA immune-complex

Recent Advances in IgA Nephropathy

Volumn , Issue , 2009, Pages 177-191

  Novak, Jan ^a   Mestecky, Jiri ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84969705671     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812835871_0013     Document Type: Chapter

References (91)

1. Berger J, Hinglais N. (1968) Les depots intercapillaires d’IgA-IgG (Intercapillary deposits of IgA-IgG). J Urol Nephrol 74: 694-695.
2. Conley ME, Cooper MD, Michael AF. (1980) Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 66: 1432-1436.
3. Emancipator SN. (1998) IgA nephropathy and Henoch-Schonlein syndrome. In: Heptinstall’s Pathology of the Kidney (eds.) Jennette JC, Olson JL, Schwartz MM, Silva FG. Lippincott-Raven Publishers, Philadelphia, pp. 479-539.
4. Coppo R, Amore A, Cirina P, et al. (1995) IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation. Nephrol Dial Transplant 10: 2310-2315.
5. Coppo R, Amore A, Cirina P, et al. (1995) Characteristics of IgA and macromolecular IgA in sera from IgA nephropathy transplanted patients with and without IgAN recurrence. Contrib Nephrol 111: 85-92.
6. Berger J. (1988) Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 12: 371-372.
7. Odum J, Peh CA, Clarkson AR, et al. (1994) Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9: 309-312.
8. Chandrakantan A, Ratanapanichkich P Said M, et al. (2005) Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil. Nephrol Dial Transplant 20: 1214-1221.
9. Silva FG, Chander P Pirani CL, et al. (1982) Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 33: 241-246.
10. Czerkinsky C, Koopman WJ, Jackson S, et al. (1986) Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 77: 1931-1938.
11. Coppo R, Basolo B, Piccoli G, et al. (1984) IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schonlein nephritis. Clin Exp Immunol 57: 583-590.
12. Tomana M, Matousovic K, Julian BA, et al. (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52: 509-516.
13. 2antibodies in patients with primary IgA nephropathy. Clin Exp Immunol 77: 15-20.
14. Tomana M, Novak J, Julian BA, et al. (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104: 73-81.
15. Gonzales-Cabrero J, Egido J, Mampaso F, et al. (1989) Characterization of circulating idiotypes containing immune complexes and their presence in the glomerular mesangium in patients with IgA nephropathy. Clin Exp Immunol 76: 204-209.
16. van den Wall Bake AWL, Bruijn JA, Accavitti MA, et al. (1993) Shared idio- types in mesangial deposits in IgA nephropathy are not disease-specific. Kidney Int 44: 65-74.
17. Coppo R, Basolo B, Martina G, et al. (1982) Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schonlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol 18: 230-239.
18. Novak J, Vu HL, Novak L, et al. (2002) Interactions of human mesangial cells with IgA and IgA-containing circulating immune complexes. Kidney Int 62: 465-475.
19. Novak J, Tomana M, Matousovic K, et al. (2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesan- gial cells. Kidney Int 67: 504-513.
20. Allen AC, Bailey EM, Brenchley PEC, et al. (2001) Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 60: 969-973.
21. Hiki Y, Odani H, Takahashi M, et al. (2001) Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59: 1077-1085.
22. Allen AC, Willis FR, Beattie TJ, et al. (1998) Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 13: 930-934.
23. Levinsky RJ, Barratt TM. (1979) IgA immune complexes in Henoch- Schonlein purpura. Lancet 2: 1100-1103.
24. van der Helm-van Mil AHM, Smith AC, Pouria S, et al. (2003) Immunoglobulin A multiple myeloma presenting with Henoch-Schonlein purpura associated with reduced sialylation of IgA1. Br J Haematol 122: 915-917.
25. Zickerman AM, Allen AC, Talwar V, et al. (2000) IgA myeloma presenting as Henoch-Schonlein purpura with nephritis. Am J Kidney Dis 36: E19.
26. Mestecky J, Moro I, Underdown BJ. (1999) Mucosal immunoglobulins. In: Mucosal Immunology (eds.) Ogra PL, Mestecky J, Lamm ME, Strober W Bienenstock J, McGhee JR. Academic Press, San Diego, pp. 133-352.
27. Mestecky J. (1988) Immunobiology of IgA. Am J Kidney Dis 12: 378-383.
28. Mestecky J, Lue C, Tarkowski A, et al. (1989) Comparative studies of the biological properties of human IgA subclasses. Protides Biol Fluids 36: 173-182.
29. Mestecky J, Moro I, Kerr MA, et al. (2005) Mucosal immunoglobulins. In: Mucosal Immunology, 3rd ed. (eds.) Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W. Elsevier Academic Press, Amsterdam, pp. 153-181.
30. Baenziger J, Kornfeld S. (1974) Structure of the carbohydrate units of IgA1 immunoglobulin II. Structure of the O-glycosidically linked oligosaccharide units. J Biol Chem 249: 7270-7281.
31. Field MC, Dwek RA, Edge CJ, et al. (1989) O-linked oligosaccharides from human serum immunoglobulin A1. Biochem Soc Trans 17: 1034-1035.
32. Mattu TS, Pleass RJ, Willis AC, et al. (1998) The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosy- lation on Fca receptor interactions. J Biol Chem 273: 2260-2272.
33. Tomana M, Kulhavy R, Mestecky J. (1988) Receptor-mediated binding and uptake of immunoglobulin A by human liver. Gastroenterology 94: 887-892.
34. Tarelli E, Smith AC, Hendry BM, et al. (2004) Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. Carbohydr Res 339: 2329-2335.
35. Renfrow MB, Cooper HJ, Tomana M, et al. (2005) Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform-ion cyclotron resonance mass spectrometry. J Biol Chem 280: 19136-19145.
36. Renfrow MB, MacKay CL, Chalmers MJ, et al. (2007) Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy. Anal Bioanal Chem 389: 1397-1407.
37. Novak J, Tomana M, Kilian M, et al. (2000) Heterogeneity of O-glycosylation in the hinge region of human IgA1. Mol Immunol 37: 1047-1056.
38. Allen AC, Harper SJ, Feehally J. (1995) Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 100: 470-474.
39. Hiki Y, Horii A, Iwase H, et al. (1995) O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role. Contrib Nephrol 111: 73-84.
40. Mestecky J, Tomana M, Crowley-Nowick PA, et al. (1993) Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 104: 172-182.
41. Leung JC, Tang SC, Chan DT, et al. (2002) Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy. J Clin Lab Anal 16: 11-19.
42. Leung JCK, Poon PYK, Lai KN. (1999) Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy? J Lab Clin Med 133: 152-160.
43. Suen KK, Lewis WH, Lai KN. (1997) Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay. Scand J Urol Nephrol 31: 289-293.
44. Suzuki H, Moldoveanu Z, Hall S, et al. (2008) IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 118: 629-639.
45. Schachter H, McGuire EJ, Roseman S. (1971) Sialic acids. XIII. A uridine diphosphate D-galactose: mucin galactosyltransferase from porcine sub- maxillary gland. J Biol Chem 246: 5321-5328.
46. Novak J, Julian BA, Tomana M, et al. (2001) Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 21: 310-327.
47. Buck KS, Smith AC, Molyneux K, et al. (2008) B-cell O-galactosyltrans- ferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. Kidney Int 73: 1128-1136.
48. Rudd PM, Elliott T, Cresswell P, et al. (2001) Glycosylation and the immune system. Science 291: 2370-2376.
49. Yeaman GR, Collins JE, Lang GA. (2002) Autoantibody responses to carbohydrate epitopes in endometriosis. Ann N Y Acad Sci 955: 174-182; discussion 199-200, 396-406.
50. Ju T, Cummings RD. (2005) Protein glycosylation: chaperone mutation in Tn syndrome. Nature 437: 1252.
51. Chui D, Sellakumar G, Green RS, et al. (2001) Genetic remodeling of protein glycosylation in vivo induces autoimmune disease. Proc Natl Acad Sci USA 98: 1142-1147.
52. Kobata A. (1998) A retrospective and prospective view of glycopathology. Glycoconj J 15: 323-331.
53. Vainchenker W, Vinci G, Testa U, et al. (1985) Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome. J Clin Invest 75: 541-546.
54. Thurnher M, Rusconi S, Berger EG. (1993) Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome. J Clin Invest 91: 2103-2110.
55. Berger EG. (1999) Tn-syndrome. Biochim Biophys Acta 1455: 255-268.
56. Julian BA, Novak J. (2004) IgA nephropathy: an update. Curr Opin Nephrol Hypertens 13: 171-179.
57. Kokubo T, Hiki Y, Iwase H, et al. (1999) Exposed peptide core of IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 14: 81-85.
58. Kokubo T, Hashizume K, Iwase H, et al. (2000) Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 15: 28-33.
59. Suzuki H, Moldoveanu Z, Hall S, et al. (2007) IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1. Contrib Nephrol 157: 129-133.
60. Mestecky J, Suzuki H, Yanagihara T, et al. (2007) IgA nephropathy: current views of immune complex formation. Contrib Nephrol 157: 56-63.
61. Mestecky J, Tomana M, Moldoveanu Z, et al. (2008) The role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy. Kidney Blood Pres Res 31: 29-37.
62. Novak J, Moldoveanu Z, Renfrow MB, et al. (2007) IgA nephropathy and Henoch-Schonlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol 157: 134-138.
63. Haakenstad AO, Mannik M. (1977) The biology of immune complexes. In: Autoimmunity. Genetic, Immunologic, Virologic, and Clinical Aspects (ed.) Talal N. Academic Press, New York, pp. 277-360.
64. Moldoveanu Z, Epps JM, Thorpe SR, et al. (1988) The sites of catabolism of murine monomeric IgA. J Immunol 141: 208-213.
65. Moldoveanu Z, Moro I, Radl J, et al. (1990) Site of catabolism of autologous and heterologous IgA in non-human primates. Scand J Immunol 32: 577-583.
66. Stockert RJ, Kressner MS, Collins JD, et al. (1982) IgA interactions with the asialoglycoprotein receptor. Proc Natl Acad Sci USA 79: 6229-6231.
67. Stockert RJ, Haimes HB, Morell AG, et al. (1980) Endocytosis of asialogly- coprotein-enzyme conjugates by hepatocytes. Lab Invest 43: 556-563.
68. Baenziger JU, Fiete D. (1980) Galactose and N-acetylgalactosamine- specific endocytosis of glycopeptides by isolated rat hepatocytes. Cell 22: 611-620.
69. Baenziger JU, Maynard Y. (1980) Human hepatic lectin. Physicochemical properties and specificity. J Biol Chem 255: 4607-4613.
70. Phillips JO, Russell MW, Brown TA, et al. (1984) Selective hepatobiliary transport of human polymeric IgA in mice. Mol Immunol 21: 907-914.
71. Phillips JO, Stohrer R, Russell MW, et al. (1986) Analysis of the hepatobiliary transport of IgA with monoclonal anti-idiotype and anti-allotype antibodies. Mol Immunol 23: 339-346.
72. Mestecky J, Hashim OH, Tomana M. (1995) Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1. Contrib Nephrol 111: 66-72.
73. Phillips JO, Komiyama K, Epps JM, et al. (1988) Role of hepatocytes in the uptake of IgA and IgA-containing immune complexes in mice. Mol Immunol 25: 873-879.
74. Couser WG. (1999) Glomerulonephritis. Lancet 353: 1509-1515.
75. Coppo R, Amore A. (2004) Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 65: 1544-1547.
76. Novak J, Julian BA, Tomana M, et al. (2008) IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy. Semin Nephrol 28: 78-87.
77. Pouria S, Barratt J. (2008) Secondary IgA nephropathy. Semin Nephrol 28: 27-37.
78. McGuire BM, Julian BA, Bynon JS, Jr, et al. (2006) Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med 144: 735-741.
79. Mestecky J, Russell MW. (1986) IgA subclasses. Monogr Allergy 19: 277-301.
80. van de Wiel A, Schuurman HJ, Kater L. (1989) Alcohol and the IgA immune system. Protides Biol Fluids 36: 247-253.
81. Julian BA, Wittke S, Novak J, et al. (2007) Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases. Electrophoresis 28: 4469-4483.
82. Julian BA, Wittke S, Novak J, et al. (2007) Urinary polypeptide biomarkers of IgA-associated renal diseases. J Am Soc Nephrol 18: 782A.
83. Amore A, Cirina P Conti G, et al. (2001) Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells. J Am Soc Nephrol 12: 1862-1871.
84. Chen A, Chen WP Sheu LF, et al. (1994) Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J Pathol 173: 119-126.
85. Leung JCK, Tsang AWL, Chan DTM, et al. (2000) Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells. J Am Soc Nephrol 11: 241-249.
86. Leung JC, Tsang AW, Chan LY, et al. (2002) Size-dependent binding of IgA to HepG2, U937, and human mesangial cells. J Lab Clin Med 140: 398-406.
87. Leung JC, Tang SC, Chan LY, et al. (2003) Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant 18: 36-45.
88. Gomez-Guerrero C, Gonzalez E, Hernando P et al. (1993) Interaction of mesangial cells with IgA and IgG immune complexes: a possible mechanism of glomerular injury in IgA nephropathy. Contrib Nephrol 104: 127-137.
89. Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E, et al. (1994) Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-a and IL-6, and proliferation. J Immunol 153: 5247-5255.
90. Moura IC, Arcos-Fajardo M, Sadaka C, et al. (2004) Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 15: 622-634.
91. Yancey KB, Lawley TJ (eds.) (2001) Circulating immune complexes and serum sickness. In: Clinical Immunology, 2nd ed. (eds.) Rich RR, Fleisher TA, Shearer WT, Kotzin BL, Schroeder HW. Mosby, London, Vol. 59, pp. 51-100.